Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
300006.SZ Stock Price Chart
Explore Chongqing Lummy Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300006.SZ price movements and trends.
300006.SZ Company Profile
Discover essential business fundamentals and corporate details for Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
30 Oct 2009
Employees
1.02K
Website
https://www.cqlummy.comCEO
Rongzhao Qiu
Description
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
300006.SZ Financial Timeline
Browse a chronological timeline of Chongqing Lummy Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Apr 2025
EPS came in at -¥0.06 , while revenue for the quarter reached ¥189.95M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.01 , while revenue for the quarter reached ¥198.40M .
Earnings released on 29 Sept 2024
EPS came in at -¥0.03 , while revenue for the quarter reached ¥223.90M .
Earnings released on 29 Jun 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥195.75M .
Earnings released on 12 Apr 2024
EPS came in at ¥0.04 , while revenue for the quarter reached ¥245.81M .
Earnings released on 31 Mar 2024
EPS came in at -¥0.00 , while revenue for the quarter reached ¥181.12M .
Earnings released on 28 Dec 2023
EPS came in at -¥0.05 , while revenue for the quarter reached ¥227.21M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.00 , while revenue for the quarter reached ¥190.90M .
Earnings released on 31 Mar 2023
EPS came in at -¥0.00 , while revenue for the quarter reached ¥226.65M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.03 , while revenue for the quarter reached ¥213.73M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥264.42M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.02 , while revenue for the quarter reached ¥207.72M .
Earnings released on 25 Apr 2022
EPS came in at -¥0.03 , while revenue for the quarter reached ¥198.71M .
Earnings released on 26 Mar 2022
EPS came in at -¥0.09 , while revenue for the quarter reached ¥333.52M .
Earnings released on 28 Oct 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥279.73M .
Earnings released on 30 Jul 2021
EPS came in at -¥0.02 , while revenue for the quarter reached ¥251.68M .
Earnings released on 24 Apr 2021
EPS came in at -¥0.36 , while revenue for the quarter reached ¥511.91M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥360.29M .
Earnings released on 28 Oct 2020
EPS came in at ¥0.01 , while revenue for the quarter reached ¥473.01M .
300006.SZ Stock Performance
Access detailed 300006.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.